RBCC Opens Talks to Acquire Tech Innovators in $142 Billion Drug Delivery Market
Wednesday, May 22, 2013
Talks come as part of the company’s push to carve out a share of the $142 billion U.S. drug delivery market.
Successful Validation and Approval of the PapilloCheck HPV Test
Wednesday, May 22, 2013
The PapilloCheck HPV test from Greiner Bio-One GmbH has now received approval from the Dutch Society for Pathology.
ATARiS Informatics Platform Hits the Jackpot
Wednesday, May 22, 2013
ATARiS is one of several tools developed at the Broad Institute to precisely tune in to the signals within noisy datasets.
G-BA Issues Final Assessment Report for PIXUVRI®
Tuesday, May 21, 2013
Pricing negotiations to begin in June.
miRNA Regulated Networks Identified in Cystic Fibrosis
Tuesday, May 21, 2013
The IDT newsletter DECODED features the latest research to rescue the CFTR functionality.
Finding, Fighting the Fat that Fuels Cancer
Monday, May 20, 2013
UT Southwestern research examines role of certain fat cells in tumorigenesis.
Novozymes Biopharma Helps Innovative Dry Eye Therapy Move into Clinical Trials
Monday, May 20, 2013
A novel ophthalmic solution has recently obtained FDA approval to undergo Phase I/II clinical trials in the United States.
Elan Announces Transactions: Decisively Transforming the Company
Monday, May 20, 2013
Upon shareholder approval, the totality of these strategically driven decisions will form a dynamic and unique business foundation for Elan in the years ahead.
Nuvilex, Inc. and Celgene, Corp. Can Both Replace Eli Lilly's Cancer Drug Gemzar
Monday, May 20, 2013
The race is on, and patients with advanced stage, inoperable pancreatic cancer will be the recipients of the winner's treatment.
|
|
|
| << | 1 2 3 4 5 6 7 | >> | | Showing Results 1 - 10 of 2375 |
|
|
